£98.66

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Pharmacy - Dispensing

Price data last checked 155 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£99 today · cheaper than every other day in the last 6 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 33 days • 13 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 33 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £104 (9 days, 69.2%)

Price range: £99 - £104

Price levels: 2 different prices over 13 days

Description

The field of antibody-drug conjugates (ADCs) has undergone remarkable advancements in recent years, marked by significant progress in both drug approvals and ongoing clinical development. Since the approval of the first ADC in 2010 (gemtuzumab ozogamicin, Mylotarg®), the landscape has expanded dramatically. Today, there are 11 FDA-approved ADCs, targeting a variety of cancers across multiple indications. The approved ADCs include a range of payloads, linkers, and antibodies, each optimized for a variety of specific therapeutic targets. The increasing diversity of ADCs reflects the growing potential of these innovative treatments to address a wide array of malignancies, from hematologic cancers to solid tumors. This book aims to provide a comprehensive overview of the current state of the ADC field including the latest developments, challenges, and emerging trends, comprising expertise from a broad range of disciplines from basic research, industry, clinical practice and regulatory affairs. We explore not only the scientific and technical aspects of ADC design―such as payloads, linkers, and antibody selection―but also the developmental hurdles and regulatory complexities that influence the success of ADCs in clinical practice. Real-world examples of ADCs that have made it from the lab to the clinic offer invaluable insights into the trials and triumphs that shape this dynamic field. It is our hope that this book will serve as both a valuable resource for experts in the field and an accessible introduction for those new to the exciting world of ADCs.

Product Specifications

Format: hardcover
ASIN: 3031830040
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 16 April 2025
Listed Since: 10 December 2024

Barcode

No barcode data available

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

Innovations for Next-Generation Antibody-Drug Conjugates (Cancer Drug Discovery and Development)

Immunotherapy in Translational Cancer Research (Translational Oncology)

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Biomarkers for Immunotherapy of Cancer: Methods and Protocols: 2055 (Methods in Molecular Biology, 2055)

Critical Developments in Cancer Immunotherapy

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Tumor Immunology: Methods and Protocols: 1393 (Methods in Molecular Biology, 1393)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Cancer Immunoprevention: Methods and Protocols: 2435 (Methods in Molecular Biology, 2435)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Small Molecules for Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Handbook of Targeted Cancer Therapy and Immunotherapy

Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses)

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses)

The 2023 Report on NDDS in Cancer Therapies: World Market Segmentation by City

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Phase I Oncology Drug Development